Abstract:Breast cancer (BC) is a highly metastatic multifactorial disease with various histological and molecular subtypes. Due to recent advancements, the mortality rate in BC has improved over the past five decades. Detection and treatment of many cancers are now possible due to the application of nanomedicine in clinical practice. Nanomedicine products such as Doxil® and Abraxane® have already been extensively used for BC adjuvant therapy with favorable clinical outcomes. However, these products were designed initially for generic anticancer purposes and not specifically for BC treatment. With a better understanding of the molecular biology of BC, several novel and promising nanotherapeutic strategies and devices have been developed in recent years. In this context, multi-functionalized nanostructures are becoming potential carriers for enhanced chemotherapy in BC patients. To design these nanostructures, a wide range of materials, such as proteins, lipids, polymers, and hybrid materials, can be used and tailored for specific purposes against BC. Selective targeting of BC cells results in the activation of programmed cell death in BC cells and can be considered a promising strategy for managing triple-negative BC. Currently, conventional BC screening methods such as mammography, digital breast tomosynthesis (DBT), ultrasonography, and magnetic resonance imaging (MRI) are either costly or expose the user to hazardous radiation that could harm them. Therefore, there is a need for such analytical techniques for detecting BC that are highly selective and sensitive, have a very low detection limit, are durable, biocompatible, and reproducible. In detecting BC biomarkers, nanostructures are used alone or in conjunction with numerous molecules. This review intends to highlight the recent advances in nanomedicine in BC treatment and diagnosis, emphasizing the targeting of BC cells that overexpress receptors of epidermal growth factors. Researchers may gain insight from these strategies to design and develop more tailored nanomedicine for BC to achieve further improvements in cancer specificity, antitumorigenic effects, anti-metastasis effects, and drug resistance reversal effects.

Innovative Nanoscale Drug Delivery Strategies for Breast Carcinoma: A Comprehensive Exploration

Nano-drug delivery system: a promising approach against breast cancer

Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment

Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment

Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer

Cutting-edge Approaches for Targeted Drug Delivery in Breast Cancer: Beyond Conventional Therapies

A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC)

Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

Nanoscale strides: exploring innovative therapies for breast cancer treatment

Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements

Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy

Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer

A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy

Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses

Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics-a comprehensive review

Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges

Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting

Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy

Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives

Advanced Targeted Drug Delivery of Bioactive Nanomaterials in the Management of Cancer